BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 27699447)

  • 1. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
    Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
    Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
    Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
    Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
    Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
    Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
    Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
    Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
    Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
    Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
    Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
    Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia.
    Kurt B; Flynn P; Shenep JL; Pounds S; Lensing S; Ribeiro RC; Pui CH; Razzouk BI; Rubnitz JE
    Cancer; 2008 Jul; 113(2):376-82. PubMed ID: 18459178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
    Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study.
    Van Weelderen RE; Klein K; Goemans BF; Tissing WJE; Wolfs TFW; Kaspers GJL
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
    Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J
    J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
    Yeh TC; Hou JY; Huang TH; Lu CH; Sun FJ; Huang HM; Liu HC
    Sci Rep; 2021 Oct; 11(1):21142. PubMed ID: 34707164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia.
    Okamoto Y; Ribeiro RC; Srivastava DK; Shenep JL; Pui CH; Razzouk BI
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):696-703. PubMed ID: 12972804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Effects of Intravenous Vancomycin-Based Prophylaxis during Therapy for Pediatric Acute Myeloid Leukemia.
    Sun Y; Huskey RL; Tang L; Inaba H; Gaur AH; Ribeiro R; Rubnitz JE; Wolf J
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Observational Assessment of the Impact of Cefepime Prophylaxis in Neutropenic Pediatric Patients With Acute Myelogenous Leukemia.
    Almatrafi MA; Dassner AM; Aquino V; Slone T; Sebert M
    J Pediatric Infect Dis Soc; 2023 Aug; 12(8):471-476. PubMed ID: 37591306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
    Ahmed R; Hassall T; Morland B; Gray J
    Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
    Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.